⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARQT News
Arcutis Biotherapeutics, Inc. Common Stock
Form 8-K
sec.gov
ARQT
ABBV
AMGN
PFE
JNJ
Arcutis Appoints Rob Scott, MD to Board of Directors
globenewswire.com
ARQT
Arcutis Management to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
globenewswire.com
ARQT
Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026
globenewswire.com
ARQT
Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical
globenewswire.com
ARQT
Arcutis’ ZORYVE® (roflumilast) Wins 2026 Marie Claire Beauty Award
globenewswire.com
ARQT
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ARQT
Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options
globenewswire.com
ARQT
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
prnewswire.com
SPGI
BE
ILMN
DELL
PANW
ANET
SNDK
NKE
SPG
CL
TAP
TTD
BLDR
HUBS
AGNC
CORT
EAT
SAM
CPRI
HRI
DK
AXTI
ARQT
ATRC
NABL
SHEN
MATW
VRRM
FBRT
NXRT
AMSF
CCOI
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ARQT